{"id":35080,"date":"2014-01-13T15:08:22","date_gmt":"2014-01-13T20:08:22","guid":{"rendered":"http:\/\/asweetlife.org\/?post_type=news&#038;p=35080"},"modified":"2015-12-30T02:40:19","modified_gmt":"2015-12-30T07:40:19","slug":"fda-approves-farxiga-astrazeneca-and-bristol-myers-squib-new-type-2-diabetes-treatment","status":"publish","type":"post","link":"https:\/\/asweetlife.org\/?p=35080","title":{"rendered":"FDA Approves Farxiga, AstraZeneca and Bristol-Myers Squib New Type 2 Diabetes Treatment"},"content":{"rendered":"<div style=\"text-align: justify;\"><a href=\"https:\/\/asweetlife.org\/wp-content\/uploads\/2014\/01\/Forxiga-Dapagliflozin-1.jpg\" rel=\"mfp\"><img decoding=\"async\" class=\"alignleft size-full wp-image-35081 lazyload\" title=\"Forxiga (Dapagliflozin)\" src=\"data:image\/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==\" data-src=\"https:\/\/asweetlife.org\/wp-content\/uploads\/2014\/01\/Forxiga-Dapagliflozin-1.jpg\" alt=\"Forxiga (Dapagliflozin)\" width=\"271\" height=\"186\" \/><\/a>The U.S. Food and Drug Administration (FDA) has approved AstraZeneca and Bristol-Myers Squib new type 2 diabetes treatment,\u00a0Farxiga (dapagliflozin), a once-daily oral treatment indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.\u00a0<\/div>\n<div>\n<div style=\"text-align: justify;\">\u00a0<\/div>\n<div style=\"text-align: justify;\">Farxiga is part of a newer class of medicines called sodium-glucose cotransporter 2 (SGLT2) inhibitors, which remove glucose via the kidneys.\u00a0(Last year the FDA approved J&amp;J&#8217;s SGLT-2 inhibitor\u00a0<a href=\"https:\/\/asweetlife.org\/feature\/how-invokana-works-new-type-2-diabetes-drug-hailed-as-a-major-treatment-advance\/\" target=\"_blank\">Invokana<\/a>, which works similarly.)<\/div>\n<div style=\"text-align: justify;\">\u00a0<\/div>\n<p style=\"text-align: justify;\">The recommended starting dose of Farxiga is 5 mg once daily, taken in the morning, with or without food. In patients tolerating Farxiga 5 mg once daily who require additional glycemic control, the dose can be increased to 10 mg once daily.<\/p>\n<p style=\"text-align: justify;\">Farxiga should not be used for the treatment of patients with type 1 diabetes or diabetic ketoacidosis.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>The U.S. Food and Drug Administration (FDA) has approved AstraZeneca and Bristol-Myers Squib new type 2 diabetes treatment, Farxiga (dapagliflozin), a once-daily oral treatment indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. <\/p>\n","protected":false},"author":131,"featured_media":35081,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1442],"tags":[1332],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.9 (Yoast SEO v22.9) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>FDA Approves Farxiga, AstraZeneca and Bristol-Myers Squib New Type 2 Diabetes Treatment<\/title>\n<meta name=\"description\" content=\"The U.S. FDA has approved AstraZeneca and Bristol-Myers Squib new once-daily oral type 2 diabetes treatment, Farxiga (dapagliflozin).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/asweetlife.org\/?p=35080\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ASweetLife Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/asweetlife.org\/?p=35080\",\"url\":\"https:\/\/asweetlife.org\/?p=35080\",\"name\":\"FDA Approves Farxiga, AstraZeneca and Bristol-Myers Squib New Type 2 Diabetes Treatment\",\"isPartOf\":{\"@id\":\"https:\/\/asweetlife.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/asweetlife.org\/?p=35080#primaryimage\"},\"image\":{\"@id\":\"https:\/\/asweetlife.org\/?p=35080#primaryimage\"},\"thumbnailUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2014\/01\/Forxiga-Dapagliflozin-1.jpg\",\"datePublished\":\"2014-01-13T20:08:22+00:00\",\"dateModified\":\"2015-12-30T07:40:19+00:00\",\"author\":{\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585\"},\"description\":\"The U.S. FDA has approved AstraZeneca and Bristol-Myers Squib new once-daily oral type 2 diabetes treatment, Farxiga (dapagliflozin).\",\"breadcrumb\":{\"@id\":\"https:\/\/asweetlife.org\/?p=35080#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/asweetlife.org\/?p=35080\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/?p=35080#primaryimage\",\"url\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2014\/01\/Forxiga-Dapagliflozin-1.jpg\",\"contentUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2014\/01\/Forxiga-Dapagliflozin-1.jpg\",\"width\":271,\"height\":186,\"caption\":\"Forxiga (Dapagliflozin)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/asweetlife.org\/?p=35080#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/asweetlife.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA Approves Farxiga, AstraZeneca and Bristol-Myers Squib New Type 2 Diabetes Treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/asweetlife.org\/#website\",\"url\":\"https:\/\/asweetlife.org\/\",\"name\":\"ASweetLife\",\"description\":\"The Diabetes Magazine\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/asweetlife.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585\",\"name\":\"ASweetLife Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g\",\"caption\":\"ASweetLife Team\"},\"url\":\"https:\/\/asweetlife.org\/?author=131\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"FDA Approves Farxiga, AstraZeneca and Bristol-Myers Squib New Type 2 Diabetes Treatment","description":"The U.S. FDA has approved AstraZeneca and Bristol-Myers Squib new once-daily oral type 2 diabetes treatment, Farxiga (dapagliflozin).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/asweetlife.org\/?p=35080","twitter_misc":{"Written by":"ASweetLife Team","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/asweetlife.org\/?p=35080","url":"https:\/\/asweetlife.org\/?p=35080","name":"FDA Approves Farxiga, AstraZeneca and Bristol-Myers Squib New Type 2 Diabetes Treatment","isPartOf":{"@id":"https:\/\/asweetlife.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/asweetlife.org\/?p=35080#primaryimage"},"image":{"@id":"https:\/\/asweetlife.org\/?p=35080#primaryimage"},"thumbnailUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2014\/01\/Forxiga-Dapagliflozin-1.jpg","datePublished":"2014-01-13T20:08:22+00:00","dateModified":"2015-12-30T07:40:19+00:00","author":{"@id":"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585"},"description":"The U.S. FDA has approved AstraZeneca and Bristol-Myers Squib new once-daily oral type 2 diabetes treatment, Farxiga (dapagliflozin).","breadcrumb":{"@id":"https:\/\/asweetlife.org\/?p=35080#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/asweetlife.org\/?p=35080"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/?p=35080#primaryimage","url":"https:\/\/asweetlife.org\/wp-content\/uploads\/2014\/01\/Forxiga-Dapagliflozin-1.jpg","contentUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2014\/01\/Forxiga-Dapagliflozin-1.jpg","width":271,"height":186,"caption":"Forxiga (Dapagliflozin)"},{"@type":"BreadcrumbList","@id":"https:\/\/asweetlife.org\/?p=35080#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/asweetlife.org\/"},{"@type":"ListItem","position":2,"name":"FDA Approves Farxiga, AstraZeneca and Bristol-Myers Squib New Type 2 Diabetes Treatment"}]},{"@type":"WebSite","@id":"https:\/\/asweetlife.org\/#website","url":"https:\/\/asweetlife.org\/","name":"ASweetLife","description":"The Diabetes Magazine","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/asweetlife.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585","name":"ASweetLife Team","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g","caption":"ASweetLife Team"},"url":"https:\/\/asweetlife.org\/?author=131"}]}},"_links":{"self":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/35080"}],"collection":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=35080"}],"version-history":[{"count":0,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/35080\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/media\/35081"}],"wp:attachment":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=35080"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=35080"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=35080"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}